Dermal absorption and toxicity of alpha amanitin in mice

Basit Öğe Kaydı
dc.contributor.authorKaya, Ertugrul
dc.contributor.authorSurmen, Mustafa Gani
dc.contributor.authorYaykasli, Kursat Oguz
dc.contributor.authorKarahan, Selim
dc.contributor.authorOktay, Murat
dc.contributor.authorTuran, Hakan
dc.contributor.authorColakoglu, Serdar
dc.date.accessioned2024-04-24T17:20:35Z
dc.date.available2024-04-24T17:20:35Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe fungus Amanita phalloides is known to contain two main groups of toxins: amanitins and phallotoxins. The amanitins group effectively blocks the RNA polymerase II enzyme found in eukaryotic cells. As alpha amanitin has a lethal effect on the majority of eukaryotic cells, it can be valuable as an antiparasitic or antifungal drug. It can be used externally against ectoparasites. It is critical that percutaneous applications of the alpha amanitin toxin are not harmful to the recipient. In this study, the absorption and the toxicity of percutaneous and intraperitoneal (ip) applications of 1 mg/kg alpha amanitin to mice were compared. Potential skin, liver and kidney toxicities were investigated through pathological examination. HPLC analysis was used to determine the amount of the toxin. No toxicity or toxin were found in the skin, liver, or kidneys of the mice in the control group. Interestingly, the percutaneous application group also showed no toxicity, and the toxin was not present in this group. After 24 h, Councilman-like bodies and pyknotic cells were observed in the mice in which alpha amanitin was applied intraperitoneally, demonstrating the presence of toxicity. Peak levels of alpha amanitin (mu g/mL) in the liver, kidney, and blood in the ip application group were measured at 3.3 (6 h), 0.2 (6 h) and 1.2 (1 h), respectively. The results demonstrated that the toxin was not absorbed through the skin of the mice and that the percutaneous application of alpha amanitin did not have any toxic effects. Thus, alpha amanitin may be administered percutaneously for therapeutic purposes.en_US
dc.description.sponsorshipDuzce University Scientific Research Coordinator (Duzce Universitesi Bilimsel Arastirma Projeleri Koordinatorlugu, DUBAP) [2011.04.HD.042]en_US
dc.description.sponsorshipThis study was financially supported by a research grant from Duzce University Scientific Research Coordinator (Duzce Universitesi Bilimsel Arastirma Projeleri Koordinatorlugu, DUBAP, 2011.04.HD.042).en_US
dc.identifier.doi10.3109/15569527.2013.802697
dc.identifier.endpage160en_US
dc.identifier.issn1556-9527
dc.identifier.issn1556-9535
dc.identifier.issue2en_US
dc.identifier.pmid23763309
dc.identifier.scopus2-s2.0-84887113490
dc.identifier.scopusqualityQ3
dc.identifier.startpage154en_US
dc.identifier.urihttps://doi.org/10.3109/15569527.2013.802697
dc.identifier.urihttps://hdl.handle.net/11468/19146
dc.identifier.volume33en_US
dc.identifier.wosWOS:000336731700015
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofCutaneous and Ocular Toxicology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlpha Amanitinen_US
dc.subjectDermal Absorptionen_US
dc.subjectDermal Toxicityen_US
dc.subjectHplcen_US
dc.titleDermal absorption and toxicity of alpha amanitin in miceen_US
dc.titleDermal absorption and toxicity of alpha amanitin in mice
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu